These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29674067)

  • 1. Arsenic speciation in hair and nails of acute promyelocytic leukemia (APL) patients undergoing arsenic trioxide treatment.
    Chen B; Cao F; Lu X; Shen S; Zhou J; Le XC
    Talanta; 2018 Jul; 184():446-451. PubMed ID: 29674067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang Z; Zhou J; Lu X; Gong Z; Le XC
    Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speciation of arsenic in biological samples.
    Mandal BK; Ogra Y; Anzai K; Suzuki KT
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):307-18. PubMed ID: 15276410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speciation of arsenic in human nail and hair from arsenic-affected area by HPLC-inductively coupled argon plasma mass spectrometry.
    Mandal BK; Ogra Y; Suzuki KT
    Toxicol Appl Pharmacol; 2003 Jun; 189(2):73-83. PubMed ID: 12781625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.
    Guo M; Wang B; Liu S; Wang W; Gao C; Hu S; Fan S; Hai X; Zhou J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):371-378. PubMed ID: 30795697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Chen B; Cao F; Yuan C; Lu X; Shen S; Zhou J; Le XC
    Anal Bioanal Chem; 2013 Feb; 405(6):1903-11. PubMed ID: 23318765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3.
    Šlejkovec Z; Podgornik H; Černelč P; Falnoga I
    Biometals; 2016 Feb; 29(1):107-18. PubMed ID: 26671504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Guo S; Wang X; Gao C; Wu Z; Chen H; Lin L; Guo M; Gao Y; Hai X
    Toxicol Lett; 2021 Sep; 347():78-85. PubMed ID: 33865921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia.
    Yoshino Y; Yuan B; Miyashita SI; Iriyama N; Horikoshi A; Shikino O; Toyoda H; Kaise T
    Anal Bioanal Chem; 2009 Jan; 393(2):689-97. PubMed ID: 19009285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic speciation in the blood of arsenite-treated F344 rats.
    Chen B; Lu X; Shen S; Arnold LL; Cohen SM; Le XC
    Chem Res Toxicol; 2013 Jun; 26(6):952-62. PubMed ID: 23734817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of multiple human arsenic metabolites employing high performance liquid chromatography inductively coupled plasma mass spectrometry.
    Stice S; Liu G; Matulis S; Boise LH; Cai Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():55-65. PubMed ID: 26708625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Wang X; Qian Z; Li H; Chen H; Lin L; Guo M; Hai X
    J Pharm Biomed Anal; 2021 Sep; 203():114201. PubMed ID: 34130006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speciation analysis of arsenic in urine samples from APL patients treated with single agent As
    Guo M; Li J; Fan S; Liu W; Wang B; Gao C; Zhou J; Hai X
    J Pharm Biomed Anal; 2019 Jul; 171():212-217. PubMed ID: 31009876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia.
    Kiguchi T; Yoshino Y; Yuan B; Yoshizawa S; Kitahara T; Akahane D; Gotoh M; Kaise T; Toyoda H; Ohyashiki K
    Leuk Res; 2010 Mar; 34(3):403-5. PubMed ID: 19733394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol.
    Guo M; Zhao Q; Fan S; Wu Z; Lin L; Chen H; Gao Y; Hai X
    Br J Clin Pharmacol; 2021 Oct; 87(10):4020-4026. PubMed ID: 33638869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia].
    Ni J; Chen G; Shen Z; Li X; Liu H; Huang Y; Fang Z; Chen S; Wang Z; Chen L
    Zhonghua Xue Ye Xue Za Zhi; 1997 May; 18(5):250-3. PubMed ID: 15622757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide.
    Zheng Y; Mao YF; Zhao HJ; Chen L; Wang LN; Zhang YX; Hu J; Li JM; Li XY; Zhu HM
    Exp Hematol Oncol; 2021 Feb; 10(1):10. PubMed ID: 33549147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.
    Fujisawa S; Ohno R; Shigeno K; Sahara N; Nakamura S; Naito K; Kobayashi M; Shinjo K; Takeshita A; Suzuki Y; Hashimoto H; Kinoshita K; Shimoya M; Kaise T; Ohnishi K
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):485-93. PubMed ID: 16937107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC-HG-AFS determination of arsenic species in acute promyelocytic leukemia (APL) plasma and blood cells.
    Guo M; Wang W; Hai X; Zhou J
    J Pharm Biomed Anal; 2017 Oct; 145():356-363. PubMed ID: 28711674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.
    Gao C; Hu S; Guo M; Hai X; Zhou J
    Cancer Chemother Pharmacol; 2018 Aug; 82(2):229-236. PubMed ID: 29845392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.